Highlights Beximco Pharmaceuticals Limited

Equities

BXPHARMA

BD0453BXPH04

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-07-01 pm EDT			5-day change	1st Jan Change
121 ^BDT	+2.46%		+14.69%	-17.24%

Apr. 30	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
Apr. 30	Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	Apr. 30	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	Apr. 30	CI
Beximco Pharmaceuticals to strengthen portfolio as interim profit up	Jan. 30	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 30, 2023	Jan. 30	CI
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Jan. 29	CI
Ex-dividend day for final dividend	Nov. 13	FA
Beximco Pharmaceuticals Posts Higher Fiscal Q1 Profit, Revenue	Nov. 06	MT
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 06	CI
Beximco boosts revenue in local currency but profit falls	Nov. 01	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	Nov. 01	CI
Beximco Pharmaceuticals Limited Proposes Dividend for the Year Ended June 30, 2023	23-10-20	CI
Beximco Pharmaceuticals to Tackle Ophthalmic Manufacturing Unit Deficiencies After Malta Medicines Authority Audit	23-09-11	MT
EARNINGS UPDATES: HC Slingsby profit falls, East Imperial loss narrows	23-05-02	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-01	CI
TRADING UPDATES: Ferro-Alloy eyes revenue to drop below market view	23-01-30	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-01-30	CI
Beximco Pharmaceuticals Limited Announces Cash Dividend for the Year Ended June 30, 2022	23-01-19	CI
Ex-dividend day for final dividend	22-11-21	FA
EARNINGS SUMMARY: Goodbody shifts away from Covid; Beximco profit down	22-11-11	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Beximco Pharmaceuticals Limited

Equities

BXPHARMA

BD0453BXPH04

Highlights

Filters